Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Hong Yan

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Thoracic Cancer|January 15, 2016
Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancerHua-Jun Chen, Jin-Ji Yang, Liang-Yi Fang, et al.
Journal of Thoracic Disease|September 19, 2015
Clinical efficacy of crizotinib in Chinese patients with ALK-positive non-small-cell lung cancer with brain metastasesYuan-Yuan Lei, Jin-Ji Yang, Wen-Zhao Zhong, et al.
Journal of Hematology & Oncology|March 16, 2010
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapySong Dong, Ai-Lin Guo, Zhi-Hong Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2015
A family history of cancer and lung cancer risk in never-smokers: A clinic-based case-control studyHuan Lin, Yi-Sheng Huang, Hong-hong Yan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2014
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patientsZhen Wang, Hong-Hong Yan, Jin-Ji Yang, et al.
Journal of Cancer|September 14, 2018
Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in Zi-Jun Yin, Hai-Yan Tu, Ming Fu, et al.
Journal of Thoracic Disease|August 23, 2021
Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancerLei Yang, Yun-Ting He, Jin Kang, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non-small cell lung cancerJia-Yi Deng, Ming Gao, Xue Fan, et al.
Clinical Lung Cancer|September 3, 2019
Development and Validation of a <sup>18</sup>F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of MalignancyHao-Yue Guo, Jun-Tao Lin, Hao-Hua Huang, et al.
Oncotarget|May 24, 2016
Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancerHong-Fei Gao, Jin-Ji Yang, Zhi-Hong Chen, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|January 15, 2016
Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancerHua-Jun Chen, Jin-Ji Yang, Liang-Yi Fang, et al.
Journal of Thoracic Disease|September 19, 2015
Clinical efficacy of crizotinib in Chinese patients with ALK-positive non-small-cell lung cancer with brain metastasesYuan-Yuan Lei, Jin-Ji Yang, Wen-Zhao Zhong, et al.
Journal of Hematology & Oncology|March 16, 2010
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapySong Dong, Ai-Lin Guo, Zhi-Hong Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2015
A family history of cancer and lung cancer risk in never-smokers: A clinic-based case-control studyHuan Lin, Yi-Sheng Huang, Hong-hong Yan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2014
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patientsZhen Wang, Hong-Hong Yan, Jin-Ji Yang, et al.
Journal of Cancer|September 14, 2018
Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in Zi-Jun Yin, Hai-Yan Tu, Ming Fu, et al.
Journal of Thoracic Disease|August 23, 2021
Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancerLei Yang, Yun-Ting He, Jin Kang, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non-small cell lung cancerJia-Yi Deng, Ming Gao, Xue Fan, et al.
Clinical Lung Cancer|September 3, 2019
Development and Validation of a <sup>18</sup>F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of MalignancyHao-Yue Guo, Jun-Tao Lin, Hao-Hua Huang, et al.
Oncotarget|May 24, 2016
Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancerHong-Fei Gao, Jin-Ji Yang, Zhi-Hong Chen, et al.
Pageof 12